Short-Term Soy Isoflavone Intervention in Patients with Localized Prostate Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
Table 2
Prostate Specific Antigen, Serum hormones, and Total Cholesterol in men with prostate cancer who consumed isoflavones or placebo for up to 6 weeks.